Glycopyrrolate Solution
Product Images NDC 70069-618

9 FDA label images from Somerset Therapeutics, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 70069-618). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (2fc11e36 103a 4967 9130 89ab02d9a1f0 01)

Molecular Structure (2fc11e36 103a 4967 9130 89ab02d9a1f0 01)
Chemical structure of glycopyrrolate showing its molecular formula C19H28BrNO3 and molecular weight 398.33.*
FDA Label Image

20 mL Vial Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 02)

20 mL Vial Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 02)
Label for Glycopyrrolate Injection, USP solution at 0.2 mg/mL strength (4 mg/20 mL total) in a 20 mL multiple dose vial. The label states it contains benzyl alcohol as a preservative and is for intramuscular or intravenous administration. Manufactured for Somerset Therapeutics, LLC, Somerset, NJ, made in India.*
FDA Label Image

20 mL Carton Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 03)

20 mL Carton Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 03)
Label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) solution for injection, for intramuscular or intravenous use. Package contains 10 multiple dose vials of 20 mL each. Manufactured by Somerset Therapeutics, LLC. Warning indicates not for use in newborns and the product contains benzyl alcohol.*
FDA Label Image

1 mL Vial Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 04)

1 mL Vial Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 04)
Label for Glycopyrrolate Injection, USP 0.2 mg/mL solution in a 1 mL single dose vial. The injectable solution is for intramuscular or intravenous administration and contains benzyl alcohol. It is manufactured for Somerset Therapeutics, LLC, Somerset, NJ, and made in India. The label includes a barcode and states the product is Rx only, with a warning 'Not for use in newborns.'*
FDA Label Image

1 mL Carton Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 05)

1 mL Carton Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 05)
Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL solution for intramuscular and intravenous use. The label indicates 25 x 1 mL single dose vials, containing benzyl alcohol preservative. Manufactured for Somerset Therapeutics, LLC, Somerset, NJ.*
FDA Label Image

2 mL Vial Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 06)

2 mL Vial Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 06)
Label for Glycopyrrolate Injection, USP solution, 0.4 mg/2 mL (0.2 mg/mL) in a 2 mL single dose vial. It is for intramuscular or intravenous administration and contains benzyl alcohol. The product is manufactured for Somerset Therapeutics, LLC, Somerset, NJ, and made in India. The label includes a barcode and an area for overprinting lot and expiration information.*
FDA Label Image

2 mL Carton Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 07)

2 mL Carton Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 07)
Packaging label for Glycopyrrolate Injection, USP 0.4 mg/2 mL solution (0.2 mg/mL) for intramuscular or intravenous use. The label states "Not for use in newborns" and that the product contains benzyl alcohol. It is manufactured by Somerset Therapeutics, LLC. The package contains 25 single-dose 2 mL vials. Storage instructions and a barcode are visible.*
FDA Label Image

5 mL Vial Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 08)

5 mL Vial Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 08)
Label for Glycopyrrolate Injection, USP 0.2 mg/mL (1 mg/5 mL) in a 5 mL multiple dose vial. The label indicates it contains benzyl alcohol, is for intramuscular or intravenous use, and includes storage instructions at controlled room temperature. Manufactured for Somerset Therapeutics, LLC, made in India.*
FDA Label Image

5 mL Carton Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 09)

5 mL Carton Label (2fc11e36 103a 4967 9130 89ab02d9a1f0 09)
Packaging label for Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) solution for intramuscular and intravenous use. The label indicates a multiple dose vial package of 25 vials, labeled by Somerset Therapeutics, LLC. It includes warnings such as 'NOT FOR USE IN NEWBORNS' and notes the presence of benzyl alcohol as a preservative.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.